A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis
Clinical trial NCT06028438 · COMPLETED
Trial details
- NCT number
- NCT06028438
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2024-08-29
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.